StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report sent to investors on Friday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Trading Up 250.0 %

Shares of Ampio Pharmaceuticals stock opened at $0.00 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $1.99. The stock has a market cap of $2,383.50, a PE ratio of 0.00 and a beta of 3.66. The company’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.01.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.